Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys
dc.contributor.author | Degenhardt, Louisa | |
dc.contributor.author | Glantz, Meyer | |
dc.contributor.author | Evans‐lacko, Sara | |
dc.contributor.author | Sadikova, Ekaterina | |
dc.contributor.author | Sampson, Nancy | |
dc.contributor.author | Thornicroft, Graham | |
dc.contributor.author | Aguilar‐gaxiola, Sergio | |
dc.contributor.author | Al‐hamzawi, Ali | |
dc.contributor.author | Alonso, Jordi | |
dc.contributor.author | Helena Andrade, Laura | |
dc.contributor.author | Bruffaerts, Ronny | |
dc.contributor.author | Bunting, Brendan | |
dc.contributor.author | Bromet, Evelyn J. | |
dc.contributor.author | Miguel Caldas De Almeida, José | |
dc.contributor.author | de Girolamo, Giovanni | |
dc.contributor.author | Florescu, Silvia | |
dc.contributor.author | Gureje, Oye | |
dc.contributor.author | Maria Haro, Josep | |
dc.contributor.author | Huang, Yueqin | |
dc.contributor.author | Karam, Aimee | |
dc.contributor.author | Karam, Elie G. | |
dc.contributor.author | Kiejna, Andrzej | |
dc.contributor.author | Lee, Sing | |
dc.contributor.author | Lepine, Jean‐pierre | |
dc.contributor.author | Levinson, Daphna | |
dc.contributor.author | Elena Medina‐mora, Maria | |
dc.contributor.author | Nakamura, Yosikazu | |
dc.contributor.author | Navarro‐mateu, Fernando | |
dc.contributor.author | Pennell, Beth‐ellen | |
dc.contributor.author | Posada‐villa, José | |
dc.contributor.author | Scott, Kate | |
dc.contributor.author | Stein, Dan J. | |
dc.contributor.author | ten Have, Margreet | |
dc.contributor.author | Torres, Yolanda | |
dc.contributor.author | Zarkov, Zahari | |
dc.contributor.author | Chatterji, Somnath | |
dc.contributor.author | Kessler, Ronald C. | |
dc.contributor.author | Adamowski, Tomasz | |
dc.date.accessioned | 2017-10-05T18:19:25Z | |
dc.date.available | 2019-01-07T18:34:37Z | en |
dc.date.issued | 2017-10 | |
dc.identifier.citation | Degenhardt, Louisa; Glantz, Meyer; Evans‐lacko, Sara ; Sadikova, Ekaterina; Sampson, Nancy; Thornicroft, Graham; Aguilar‐gaxiola, Sergio ; Al‐hamzawi, Ali ; Alonso, Jordi; Helena Andrade, Laura; Bruffaerts, Ronny; Bunting, Brendan; Bromet, Evelyn J.; Miguel Caldas De Almeida, José ; de Girolamo, Giovanni; Florescu, Silvia; Gureje, Oye; Maria Haro, Josep; Huang, Yueqin; Karam, Aimee; Karam, Elie G.; Kiejna, Andrzej; Lee, Sing; Lepine, Jean‐pierre ; Levinson, Daphna; Elena Medina‐mora, Maria ; Nakamura, Yosikazu; Navarro‐mateu, Fernando ; Pennell, Beth‐ellen ; Posada‐villa, José ; Scott, Kate; Stein, Dan J.; ten Have, Margreet; Torres, Yolanda; Zarkov, Zahari; Chatterji, Somnath; Kessler, Ronald C.; Adamowski, Tomasz (2017). "Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys." World Psychiatry 16(3): 299-307. | |
dc.identifier.issn | 1723-8617 | |
dc.identifier.issn | 2051-5545 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/138361 | |
dc.publisher | United Nations | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | Substance use disorders | |
dc.subject.other | United Nations Sustainable Development Goals | |
dc.subject.other | World Health Organization | |
dc.subject.other | treatment coverage | |
dc.subject.other | drugs | |
dc.subject.other | alcohol | |
dc.title | Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Psychiatry | |
dc.subject.hlbtoplevel | Social Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/138361/1/wps20457.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/138361/2/wps20457_am.pdf | |
dc.identifier.doi | 10.1002/wps.20457 | |
dc.identifier.source | World Psychiatry | |
dc.identifier.citedreference | First M, Spitzer R, Gibbon M et al. Structured Clinical Interview for DSMâ IV Axis I Disorders, Research Version, Nonâ patient Edition (SCIDâ I/NP). New York: Biometrics Research, New York State Psychiatric Institute, 2002. | |
dc.identifier.citedreference | Heeringa S, Wells E, Hubbard F et al. Sample designs and sampling procedures. In: Kessler R, Ustun T (eds). The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press, 2008: 14 â 32. | |
dc.identifier.citedreference | United Nations Office on Drugs and Crime. World drug report 2016. Vienna: United Nations, 2016. | |
dc.identifier.citedreference | SAS Institute Inc. Base SAS ® 9.4 procedures guide. Cary: SAS Institute Inc., 2013. | |
dc.identifier.citedreference | McCrady BS, Owens MD, Borders AZ et al. Psychosocial approaches to alcohol use disorders since 1940: a review. J Stud Alcohol Drugs Suppl 2014; 75 ( Suppl. 17 ): 68 â 78. | |
dc.identifier.citedreference | Magill M, Kiluk BD, McCrady BS et al. Active ingredients of treatment and client mechanisms of change in behavioral treatments for alcohol use disorders: progress 10 years later. Alcohol Clin Exp Res 2015; 39: 1852 â 62. | |
dc.identifier.citedreference | Sherman BJ, McRaeâ Clark AL. Treatment of cannabis use disorder: current science and future outlook. Pharmacotherapy 2016; 36: 511 â 35. | |
dc.identifier.citedreference | Gates PJ, Sabioni P, Copeland J et al. Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev 2016;5:CD005336. | |
dc.identifier.citedreference | Wang PS, Aguilarâ Gaxiola S, Alonso J et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO World Mental Health Surveys. Lancet 2007; 370: 841 â 50. | |
dc.identifier.citedreference | Lago L, Glantz M, Kessler RC et al. Substance dependence among those without symptoms of substance abuse in the World Mental Health Survey. Int J Methods Psychiatr Res (in press). | |
dc.identifier.citedreference | Forouzanfar MH, Alexander L, Anderson HR et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990â 2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 2287 â 323. | |
dc.identifier.citedreference | Volkow ND, Poznyak V, Saxena S et al. Drug use disorders: impact of a public health rather than a criminal justice approach. World Psychiatry 2017; 16: 213 â 4. | |
dc.identifier.citedreference | United Nations. Transforming our world: the 2030 agenda for sustainable development. Resolution of the United Nations General Assembly. New York: United Nations, 2015. | |
dc.identifier.citedreference | McDaid D, Knapp M, Raja S. Barriers in the mind: promoting an economic case for mental health in lowâ and middleâ income countries. World Psychiatry 2008; 7: 79 â 86. | |
dc.identifier.citedreference | Patel V, Maj M, Flisher AJ et al. Reducing the treatment gap for mental disorders: a WPA survey. World Psychiatry 2010; 9: 169 â 76. | |
dc.identifier.citedreference | World Health Organization. Atlas on substance use (2010): resources for the prevention and treatment of substance use disorders. Geneva: World Health Organization, 2010. | |
dc.identifier.citedreference | World Bank. Data: countries and economies. http://data.worldbank.org. | |
dc.identifier.citedreference | Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004; 13: 93 â 121. | |
dc.identifier.citedreference | Harkness J, Pennell B, Villar A et al. Translation procedures and translation assessment in the World Mental Health Survey Initiative. In: Kessler RC, Ustun TB (eds). The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press, 2008: 91 â 113. | |
dc.identifier.citedreference | Haro JM, Arbabzadehâ Bouchez S, Brugha TS et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys. Int J Methods Psychiatr Res 2006; 15: 167 â 80. | |
dc.identifier.citedreference | World Health Organization. Mental health action plan 2013â 2020. Geneva: World Health Organization, 2013. | |
dc.identifier.citedreference | Tomásâ Rosselló J, Rawson RA, Zarza MJ et al. United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: Treatnet. Subst Abus 2010; 31: 251 â 63. | |
dc.identifier.citedreference | Saenz E, Busse A, Tomas J et al. Major international challenges in addiction treatment: the experience of Treatnet and beyond. In: elâ Guebaly N, Carrà G, Galanter M (eds). Textbook of addiction treatment: international perspectives. Berlin: Springer, 2015: 2459 â 71. | |
dc.identifier.citedreference | Dua T, Barbui C, Clark N et al. Evidenceâ based guidelines for mental, neurological, and substance use disorders in lowâ and middleâ income countries: summary of WHO recommendations. PLoS Med 2011; 8: e1001122. | |
dc.identifier.citedreference | Barbui C, Dua T, van Ommeren M et al. Challenges in developing evidenceâ based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLoS Med 2010; 7: e1000322. | |
dc.identifier.citedreference | World Health Organization. mhGAP intervention guide for mental, neurological and substance use disorders in nonâ specialized health settings. Geneva: World Health Organization, 2010. | |
dc.identifier.citedreference | Strathdee SA, Hallett TB, Bobrova N et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 2010; 376: 268 â 84. | |
dc.identifier.citedreference | Bobrova N, Rhodes T, Power R et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend 2006; 82: S57 â 63. | |
dc.identifier.citedreference | Degenhardt L, Mathers B, Vickerman P et al. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010; 376: 285 â 301. | |
dc.identifier.citedreference | Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet 2010; 376: 355 â 66. | |
dc.identifier.citedreference | ten Have M, de Graaf R, van Dorsselaer S et al. Lifetime treatment contact and delay in treatment seeking after first onset of a mental disorder. Psychiatr Serv 2013; 64: 981 â 9. | |
dc.identifier.citedreference | Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55 â 70. | |
dc.identifier.citedreference | Reuter P, Trautmann F (eds). A report on global illicit drugs markets 1998â 2007. Utrecht: Trimbos Institute, 2009. | |
dc.identifier.citedreference | Morley KC, Logge W, Pearson Sâ A et al. National trends in alcohol pharmacotherapy: findings from an Australian claims database. Drug Alcohol Depend 2016; 166: 254 â 7. | |
dc.identifier.citedreference | Mathers B, Degenhardt L, Ali H et al. HIV prevention, treatment and care for people who inject drugs: a systematic review of global, regional and country level coverage. Lancet 2010; 375: 1014 â 28. | |
dc.identifier.citedreference | Morley KC, Teesson M, Reid SC et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multiâ centre, randomized, doubleâ blind, placeboâ controlled trial. Addiction 2006; 101: 1451 â 62. | |
dc.identifier.citedreference | Pani PP, Trogu E, Vecchi S et al. Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst Rev 2011; 12: CD002950. | |
dc.identifier.citedreference | Pani PP, Trogu E, Vacca R et al. Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev 2010; 1: CD007024. | |
dc.identifier.citedreference | Minozzi S, Amato L, Davoli M et al. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev 2008; 2: CD006754. | |
dc.identifier.citedreference | Marshall K, Gowing L, Ali R et al. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 2014; 12: CD008940. | |
dc.identifier.citedreference | Mattick RP, Kimber J, Breen C et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;2:CD002207. | |
dc.identifier.citedreference | Mattick RP, Breen C, Kimber J et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;3:CD002209. | |
dc.identifier.citedreference | Substance Abuse and Mental Health Services Administration. Result from the 2002 National Survey on Drug Use and Health: national findings. Rockville: Office of Applied Studies, 2003. | |
dc.identifier.citedreference | Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997; 92: 279 â 96. | |
dc.identifier.citedreference | World Health Organization. Global status report on alcohol and health 2014. Geneva: World Health Organization, 2014. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.